Real-World Data Abstracts
From Real-World Data to Real-World Impact
The 3rd Kidney Real-World Forum 2026 invites nephrologists, transplant physicians, researchers, fellows, allied healthcare professionals, and institutions worldwide to submit high-quality Real-World Data (RWD) abstracts.
The Forum brings together clinical evidence, real-world experience, innovation, and implementation to translate evidence into better kidney care.
Our Question: Does it work in the real world?
11 REAL-WORLD DATA CATEGORIES
01 | Glomerular Diseases & Precision Nephrology
Igan • FSGS • Membranous Nephropathy • Lupus Nephritis • Complement-Mediated Disease • Biomarkers • Targeted Therapies
02 | Genetic & Genomic Nephrology
Genetic Testing • WES/WGS • APOL1 • Alport Syndrome • Inherited Kidney Disease • Genotype–Phenotype • Precision Therapeutics
03 | Cardio-Kidney-Metabolic Medicine
CKD • Diabetes • Obesity • Hypertension • Heart Failure • SGLT2 Inhibitors • GLP-1RA • Finerenone • Combination Therapy
04 | CKD Progression & Prevention
Early CKD Detection • Risk Prediction • Albuminuria • Novel Biomarkers • Renoprotection • Disease Progression • Prevention Of Kidney Failure
05 | Dialysis Innovation & Home Kidney Care
Home HD • Peritoneal Dialysis • Incremental Dialysis • Remote Monitoring • Vascular Access • Patient-Centered Dialysis • Digital Technology
06 | Kidney Transplantation & Precision Immunosuppression
Rejection • DSA • Immunosuppression • Belatacept • Biomarkers • Donor-Derived Cfdna • Graft Survival • Post-Transplant Outcomes
07 | Onconephrology & Kidney Disease in Cancer
Immune Checkpoint Inhibitors • AKI, Glomerular Disease, TMA, Electrolyte Disorders In Cancer Patients •Nephrotoxicity • Cancer–Kidney Care
08 | Pediatric-to-Adult Transition & Lifelong Kidney Care
Transition Programs • Adolescent CKD • Pediatric Transplantation • Adherence • Psychosocial Outcomes • Continuity Of Care • Long-Term Outcomes
09 | Rare Kidney Diseases & Complement-Mediated Disorders
Ahus • C3G • Fabry Disease • Alport Syndrome • Rare Tubulopathies • Complement Disorders • Registries • Novel Therapies
10 | Advanced Transplantation, Organ Preservation & Donation
DCD • Expanded-Criteria Donors • Machine Perfusion • Organ Utilization • Allocation • Donor Optimization • Complex Transplantation • Innovative Donation
11 | Digital Nephrology, AI & Learning Health Systems
Artificial Intelligence • Predictive Analytics • Digital Pathology • Clinical Decision Support • Remote Monitoring • Registries • RWE Platforms • Healthcare Transformation
Submission Criteria
WHAT ARE WE LOOKING FOR?
We particularly welcome:
1. National & International Registries
2. Multicenter Cohorts
3. Electronic Health Record Studies
4. Prospective & Retrospective Studies
5. Implementation & Quality Improvement Studies
6. Real-World Treatment Outcomes
7. Health Economics & Value-Based Care
8. Patient-Reported Outcomes
9. Digital Health & AI Studies
Priority will be given to studies demonstrating
Clinical Relevance • Innovation • Robust Methodology • Real-World Impact • Actionable Findings
Studies from Saudi Arabia, GCC, MENA, and under-represented populations are especially encouraged.
ABSTRACT REQUIREMENTS
Number of Words:
- 300–350 as a Maximum Limit
Sections:
- Background & Objective
- Methods
- Real-World Population/Dataset
- Results
- Clinical Implications
- Conclusion
- 3–5 Keywords